tirzepatide vs semaglutide results semaglutide: A new battle in obesity treatment Comparative ocular outcomes of tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates two, producing stronger appetite suppression and greater average weight loss (2022.5% vs

Since the 1970s, iron chelation therapy has been used as an alternative to regular phlebotomy to treat excess iron stores in people with haemochromatosis

Biomed Pharmacotherapy 141:111848

AChE Activity In the prefrontal cortex, Doxorubicin and Cyclophosphamide treatment showed a significant increase in AChE activity compared to the control group by 1.8 folds

Incidence Rates Among Medication Users The study found that 0.53% of GLP-1 medication users developed gastroparesis